Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Turk

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Leukemia|October 5, 2023
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignanciesJingyu Xiang, Jessica M Devenport, Alun J Carter, et al.
The Journal of Biological Chemistry|December 18, 2007
Generation and characterization of transgenic mice with the full-length human DMD genePeter A C 't Hoen, Emile J de Meijer, Judith M Boer, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiencySara Fañanas-Baquero, Oscar Quintana-Bustamante, Daniel P Dever, et al.
Nature Medicine|August 8, 2018
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cellsChristopher A Vakulskas, Daniel P Dever, Garrett R Rettig, et al.
Molecular Therapy. Methods & Clinical Development|May 16, 2022
Pharmacological interventions enhance virus-free generation of <i>TRAC</i>-replaced CAR T cellsJonas Kath, Weijie Du, Alina Pruene, et al.
Nature Communications|June 24, 2021
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicinesLiyang Zhang, John A Zuris, Ramya Viswanathan, et al.
Nature Communications|July 20, 2021
Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicinesLiyang Zhang, John A Zuris, Ramya Viswanathan, et al.
Blood Advances|July 28, 2020
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cellsRafet Basar, May Daher, Nadima Uprety, et al.
Blood|September 9, 2020
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsMay Daher, Rafet Basar, Elif Gokdemir, et al.
Molecular Therapy. Advances|May 18, 2026
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulationGhazaleh Zarrinrad, Lisa-Marie Burkhardt, Claudia Beltran-Mestres, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Leukemia|October 5, 2023
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignanciesJingyu Xiang, Jessica M Devenport, Alun J Carter, et al.
The Journal of Biological Chemistry|December 18, 2007
Generation and characterization of transgenic mice with the full-length human DMD genePeter A C 't Hoen, Emile J de Meijer, Judith M Boer, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiencySara Fañanas-Baquero, Oscar Quintana-Bustamante, Daniel P Dever, et al.
Nature Medicine|August 8, 2018
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cellsChristopher A Vakulskas, Daniel P Dever, Garrett R Rettig, et al.
Molecular Therapy. Methods & Clinical Development|May 16, 2022
Pharmacological interventions enhance virus-free generation of <i>TRAC</i>-replaced CAR T cellsJonas Kath, Weijie Du, Alina Pruene, et al.
Nature Communications|June 24, 2021
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicinesLiyang Zhang, John A Zuris, Ramya Viswanathan, et al.
Nature Communications|July 20, 2021
Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicinesLiyang Zhang, John A Zuris, Ramya Viswanathan, et al.
Blood Advances|July 28, 2020
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cellsRafet Basar, May Daher, Nadima Uprety, et al.
Blood|September 9, 2020
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsMay Daher, Rafet Basar, Elif Gokdemir, et al.
Molecular Therapy. Advances|May 18, 2026
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulationGhazaleh Zarrinrad, Lisa-Marie Burkhardt, Claudia Beltran-Mestres, et al.
Pageof 3